Growth Metrics

Armata Pharmaceuticals (ARMP) Net Cash Flow (2016 - 2026)

Quarterly results put Net Cash Flow at -$5.2 million for Q1 2026, down 325.57% from a year ago — trailing twelve months through Mar 2026 was -$8.2 million (up 68.76% YoY), and the annual figure for FY2025 was -$693000.0, up 84.5%.

Armata Pharmaceuticals has reported Net Cash Flow over the past 14 years, most recently at -$5.2 million for Q1 2026.

  • Net Cash Flow reached -$5.2 million in Q1 2026 per ARMP's latest filing, up from -$6.1 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $40.9 million in Q1 2022 and bottomed at -$12.6 million in Q2 2023.
  • Median Net Cash Flow over the past 5 years was -$7.4 million (2025), compared with a mean of -$153764.7.
  • Peak annual rise in Net Cash Flow hit 219.23% in 2022, while the deepest fall reached 488.93% in 2022.
  • Over 5 years, Net Cash Flow stood at -$10.5 million in 2022, then decreased by 0.09% to -$10.5 million in 2023, then rose by 25.51% to -$7.8 million in 2024, then rose by 22.7% to -$6.1 million in 2025, then increased by 14.24% to -$5.2 million in 2026.
  • Business Quant data shows Net Cash Flow for ARMP at -$5.2 million in Q1 2026, -$6.1 million in Q4 2025, and $10.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 2.44 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 625.70 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 457.40 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn -152.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 60.68 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - -5.20 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.20 Mn
Mar 31, 2026 -5.20 Mn
Dec 31, 2025 -6.07 Mn
Dec 31, 2025 -6.07 Mn
Sep 30, 2025 10.43 Mn
Sep 30, 2025 10.43 Mn
Jun 30, 2025 -7.36 Mn
Jun 30, 2025 -7.36 Mn
Mar 31, 2025 2.31 Mn
Mar 31, 2025 2.31 Mn
Dec 31, 2024 -7.85 Mn
Dec 31, 2024 -7.85 Mn
Sep 30, 2024 -9.26 Mn
Sep 30, 2024 -9.26 Mn
Jun 30, 2024 -11.46 Mn
Jun 30, 2024 -11.46 Mn
Mar 31, 2024 24.10 Mn
Mar 31, 2024 24.10 Mn
Dec 31, 2023 -10.54 Mn
Dec 31, 2023 -10.54 Mn
Sep 30, 2023 11.61 Mn
Sep 30, 2023 11.61 Mn
Jun 30, 2023 -12.65 Mn
Jun 30, 2023 -12.65 Mn
Mar 31, 2023 10.01 Mn
Mar 31, 2023 10.01 Mn
Dec 31, 2022 -10.53 Mn
Dec 31, 2022 -10.53 Mn
Sep 30, 2022 -11.60 Mn
Sep 30, 2022 -11.60 Mn
Jun 30, 2022 -9.43 Mn
Jun 30, 2022 -9.43 Mn
Mar 31, 2022 40.88 Mn
Mar 31, 2022 40.88 Mn
Dec 31, 2021 -1.79 Mn
Dec 31, 2021 -1.79 Mn
Sep 30, 2021 -5.46 Mn
Sep 30, 2021 -5.46 Mn
Jun 30, 2021 -4.92 Mn
Jun 30, 2021 -4.92 Mn
Mar 31, 2021 12.81 Mn
Mar 31, 2021 12.81 Mn
Dec 31, 2020 -6.24 Mn
Dec 31, 2020 -6.24 Mn
Sep 30, 2020 -3.90 Mn
Sep 30, 2020 -3.90 Mn
Jun 30, 2020 -3.82 Mn
Jun 30, 2020 -3.82 Mn
Mar 31, 2020 18.08 Mn
Mar 31, 2020 18.08 Mn
Dec 31, 2019 -2.66 Mn
Dec 31, 2019 -2.66 Mn
Sep 30, 2019 -4.50 Mn
Sep 30, 2019 -4.50 Mn
Jun 30, 2019 7.03 Mn
Jun 30, 2019 7.03 Mn
Mar 31, 2019 -3.60 Mn
Mar 31, 2019 -3.60 Mn
Dec 31, 2018 2.36 Mn
Dec 31, 2018 2.36 Mn
Sep 30, 2018 -2.08 Mn
Sep 30, 2018 -2.08 Mn
Jun 30, 2018 -2.08 Mn
Jun 30, 2018 -2.08 Mn
Mar 31, 2018 3.07 Mn
Mar 31, 2018 3.07 Mn
Dec 31, 2017 -2.59 Mn
Dec 31, 2017 -2.59 Mn
Sep 30, 2017 -1.24 Mn
Sep 30, 2017 -1.24 Mn
Jun 30, 2017 6.76 Mn
Jun 30, 2017 6.76 Mn
Mar 31, 2017 -3.51 Mn
Mar 31, 2017 -3.51 Mn
Dec 31, 2016 1.74 Mn
Dec 31, 2016 1.74 Mn
Sep 30, 2016 -3.18 Mn
Sep 30, 2016 -3.18 Mn
Jun 30, 2016 -3.02 Mn
Jun 30, 2016 -3.02 Mn